337 related articles for article (PubMed ID: 27017221)
1. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
[TBL] [Abstract][Full Text] [Related]
2. The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.
Efthymiadou A; Kritikou D; Mantagos S; Chrysis D
Eur J Endocrinol; 2016 Apr; 174(4):473-9. PubMed ID: 26764419
[TBL] [Abstract][Full Text] [Related]
3. Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation.
Mizia-Stec K; Wieczorek J; Polak M; Wybraniec MT; Woźniak-Skowerska I; Hoffmann A; Nowak S; Wikarek M; Wnuk-Wojnar A; Chudek J; Więcek A
Cytokine; 2018 Nov; 111():106-111. PubMed ID: 30138898
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
[TBL] [Abstract][Full Text] [Related]
5. Decreased concentration of klotho and increased concentration of FGF23 in the cerebrospinal fluid of patients with narcolepsy.
da Paz Oliveira G; Elias RM; Peres Fernandes GB; Moyses R; Tufik S; Bichuetti DB; Coelho FMS
Sleep Med; 2021 Feb; 78():57-62. PubMed ID: 33385780
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
8. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
Tartaglione L; Pasquali M; Rotondi S; Muci ML; Leonangeli C; Farcomeni A; Fassino V; Mazzaferro S
PLoS One; 2017; 12(5):e0178637. PubMed ID: 28558021
[TBL] [Abstract][Full Text] [Related]
9. Soluble αKlotho as a candidate for the biomarker of aging.
Koyama D; Sato Y; Aizawa M; Maki T; Kurosawa M; Kuro-o M; Furukawa Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):1019-25. PubMed ID: 26462468
[TBL] [Abstract][Full Text] [Related]
10. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
Sawires HK; Essam RM; Morgan MF; Mahmoud RA
Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
[TBL] [Abstract][Full Text] [Related]
11. Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels.
Poelzl G; Ghadge SK; Messner M; Haubner B; Wuertinger P; Griesmacher A; Doerler J; Ensinger C; Ulmer H; Zaruba MM
Sci Rep; 2018 May; 8(1):8429. PubMed ID: 29849175
[TBL] [Abstract][Full Text] [Related]
12. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone and Klotho.
Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
[TBL] [Abstract][Full Text] [Related]
14. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
15. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
16. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
Zeng QY; Xia ZY; Tong YS; Sun L; Mou HB; Chen R; Bi GY; Liu CH
Nephrology (Carlton); 2019 Oct; 24(10):1001-1008. PubMed ID: 30537427
[TBL] [Abstract][Full Text] [Related]
17. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
Seiler S; Wen M; Roth HJ; Fehrenz M; Flügge F; Herath E; Weihrauch A; Fliser D; Heine GH
Kidney Int; 2013 Jan; 83(1):121-8. PubMed ID: 22895520
[TBL] [Abstract][Full Text] [Related]
18. [Mineral metabolism in patients on chronic peritoneal dialysis].
Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
[TBL] [Abstract][Full Text] [Related]
19. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
